On 14th April 2016 NICE published NICE Guidance (NG46) “Controlled drugs: safe use and management”.
This guideline covers systems and processes for using and managing controlled drugs safely in all NHS settings except care homes. It aims to improve working practices to comply with legislation and have robust governance arrangements. It also aims to reduce the safety risks associated with controlled drugs.
NECS Medicines Optimisation team will be producing a briefing document on the guidance including implications for CCGs, provider services and GP practices. This will be available on this website on May 26th 2016.